Inspire Medical Systems (INSP) said Monday that it signed a $75 million accelerated share repurchase agreement with Goldman Sachs (GS).
The company said the accelerated share repurchase transaction is scheduled to terminate in Q1 2025 and is under its previously announced $150 million share buyback program, which is set to expire in August 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments